Global Inflammatory Bowel Disease Market 2015-2019
Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss. Inflammatory bowel disease can also prove to be life-threatening for the patients. Ulcerative colitis generally affects the colon, where inflammation and ulcers develop in the innermost lining of the colon and the rectum of a patient. Crohn's disease causes inflammation of the lining of the GI tract. The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or both. Inflammatory bowel disease is a chronic medical condition, which has no permanent cure and demands a lifetime of treatment and management. The preferred treatment options include anti-inflammatory steroidal products and immuno-suppressive agents such as the TNF-α inhibitors. Analysts forecast the Global Inflammatory Bowel Disease market to grow at a CAGR of 3.95 percent over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-inflammatory-bowel-disease-2015-2019-market
Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss. Inflammatory bowel disease can also prove to be life-threatening for the patients. Ulcerative colitis generally affects the colon, where inflammation and ulcers develop in the innermost lining of the colon and the rectum of a patient. Crohn's disease causes inflammation of the lining of the GI tract. The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or both. Inflammatory bowel disease is a chronic medical condition, which has no permanent cure and demands a lifetime of treatment and management. The preferred treatment options include anti-inflammatory steroidal products and immuno-suppressive agents such as the TNF-α inhibitors.
Analysts forecast the Global Inflammatory Bowel Disease market to grow at a CAGR of 3.95 percent over the period 2014-2019.
Read more details at: http://www.bigmarketresearch.com/global-inflammatory-bowel-disease-2015-2019-market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Top 10 Diabetes<br />
Care Technologies,<br />
Devices and<br />
<strong>Global</strong> <strong>Inflammatory</strong><br />
Therapeutics<br />
<strong>Bowel</strong> <strong>Disease</strong> <strong>Market</strong><br />
<strong>2015</strong>-<strong>2019</strong> <strong>Market</strong>s<br />
- Growth, <strong>Global</strong> Share,<br />
Industry Overview, Analysis,<br />
Trends Opportunities and<br />
Forecast 2012 - 2020
Description<br />
Report Overview<br />
About <strong>Inflammatory</strong> <strong>Bowel</strong> <strong>Disease</strong><br />
<strong>Inflammatory</strong> bowel disease is a condition includes a group of autoimmune<br />
diseases such as Crohn's disease and ulcerative colitis. It causes chronic<br />
inflammation of a specific part or the entire GI tract. Both Crohn's disease and<br />
ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal<br />
cramps and pain, rectal bleeding, fatigue, and weight loss. <strong>Inflammatory</strong> bowel<br />
disease can also prove to be life-threatening for the patients. Ulcerative colitis<br />
generally affects the colon, where inflammation and ulcers develop in the<br />
innermost lining of the colon and the rectum of a patient. Crohn's disease causes<br />
inflammation of the lining of the GI tract. The inflammation in Crohn's disease<br />
affects various areas of the GI tract such as the large intestine and small intestine,<br />
or both. <strong>Inflammatory</strong> bowel disease is a chronic medical condition, which has no<br />
permanent cure and demands a lifetime of treatment and management<br />
Analysts forecast the <strong>Global</strong> <strong>Inflammatory</strong> <strong>Bowel</strong> <strong>Disease</strong> market to grow at a<br />
CAGR of 3.95 percent over the period 2014-<strong>2019</strong>.<br />
Read more details at: http://www.bigmarketresearch.com/globalinflammatory-bowel-disease-<strong>2015</strong>-<strong>2019</strong>-market<br />
@Bigmarketresearch
Description<br />
Report Overview<br />
Covered in this Report<br />
This report covers the present scenario and the growth prospects of the <strong>Global</strong><br />
<strong>Inflammatory</strong> <strong>Bowel</strong> <strong>Disease</strong> market for the period <strong>2015</strong>-<strong>2019</strong>. To calculate the<br />
market size, the report considers revenue generated from the sales of various<br />
drugs used in the treatment of inflammatory bowel disease. The market includes<br />
data from the sales of various drusg which are used for the treatment of Crohn's<br />
<strong>Disease</strong> and Ulcerative Colitis.<br />
On the basis of the functioning of the drugs used for treatment, the <strong>Global</strong><br />
<strong>Inflammatory</strong> <strong>Bowel</strong> <strong>Disease</strong> market is categorized into three segments.<br />
• 5-ASA<br />
• Antibiotics<br />
• Immunomodulators<br />
@Bigmarketresearch
Key Benefits<br />
Description<br />
On the basis of route of administration adopted for the treatment, the <strong>Global</strong><br />
<strong>Inflammatory</strong> <strong>Bowel</strong> <strong>Disease</strong> market is categorized into two segments.<br />
• Oral<br />
• Parenteral<br />
On the basis of the form of drug used to treat the disease, the <strong>Global</strong> <strong>Inflammatory</strong><br />
<strong>Bowel</strong> <strong>Disease</strong> market is categorized into two segments.<br />
• Solid<br />
• Liquid<br />
The report also presents the vendor landscape and a corresponding detailed<br />
analysis of the top vendors in the <strong>Global</strong> <strong>Inflammatory</strong> <strong>Bowel</strong> <strong>Disease</strong> market. The<br />
vendor landscape includes an analysis of the major vendors, along with the<br />
competitive performances of their portfolios. In addition, the report discusses the<br />
major drivers, challenges and trends influencing the market. In addition, late-stage<br />
pipeline molecules developed for the treatment of inflammatory bowel disease are<br />
discussed.<br />
@Bigmarketresearch
Description<br />
<strong>Global</strong> <strong>Inflammatory</strong> <strong>Bowel</strong> <strong>Disease</strong> <strong>Market</strong> <strong>2015</strong>-<strong>2019</strong>, has been prepared based on an<br />
in-depth market analysis with inputs from industry experts. The report covers the<br />
Americas, and the APAC and EMEA regions; it also covers the landscape of the <strong>Global</strong><br />
<strong>Inflammatory</strong> <strong>Bowel</strong> <strong>Disease</strong> market and its growth prospects in the coming years. The<br />
report also includes a discussion of the key vendors operating in this market.<br />
Key Regions<br />
• Americas<br />
• APAC<br />
• EMEA<br />
Key Vendors<br />
• Abbvie<br />
• Biogen Idec<br />
• Janssen Pharmaceuticals<br />
• Merck & Company<br />
• Shire<br />
• UCB<br />
@Bigmarketresearch
Description<br />
<strong>Market</strong> Driver<br />
• Increase in Instances of <strong>Inflammatory</strong> <strong>Bowel</strong> <strong>Disease</strong><br />
• For a full, detailed list, view our report<br />
<strong>Market</strong> Challenge<br />
• High Cost of Drugs<br />
• For a full, detailed list, view our report<br />
<strong>Market</strong> Trend<br />
• Dominance of <strong>Market</strong> by Biologics<br />
• For a full, detailed list, view our report<br />
Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/221010<br />
@Bigmarketresearch
Table Of Contents<br />
Table Of Content<br />
01. Executive Summary<br />
02. List of Abbreviations<br />
03. Scope of the Report<br />
04. <strong>Market</strong> Research Methodology<br />
05. Introduction<br />
06. <strong>Disease</strong> Overview: Crohn's <strong>Disease</strong><br />
07. <strong>Disease</strong> Overview: Ulcerative Colitis<br />
08. Pipeline Portfolio<br />
09. <strong>Market</strong> Landscape<br />
10. <strong>Market</strong> Segmentation by Type of <strong>Disease</strong><br />
11. <strong>Global</strong> Crohn's <strong>Disease</strong> <strong>Market</strong><br />
12. <strong>Global</strong> Ulcerative Colitis <strong>Market</strong><br />
13. <strong>Market</strong> Segmentation by Drug Class<br />
14. <strong>Market</strong> Segmentation by Type of Molecules<br />
15. <strong>Market</strong> Segmentation by Dosage Form<br />
16. <strong>Market</strong> Segmentation by Route of Administration<br />
17. Geographical Segmentation<br />
18. Key Leading Countries<br />
19. Buying Criteria<br />
20. <strong>Market</strong> Growth Drivers<br />
21. Drivers and their Impact<br />
22. <strong>Market</strong> Challenges<br />
23. Impact of Drivers and Challenges<br />
24. <strong>Market</strong> Trends<br />
25. Trends and their Impact<br />
26. Vendor Landscape<br />
27. Key Vendor Analysis<br />
28. Other Reports in this Series<br />
@Bigmarketresearch
Get Full Information<br />
At:<br />
http://www.bigmarketresearch.com<br />
/global-inflammatory-boweldisease-<strong>2015</strong>-<strong>2019</strong>-market
Change language